Sometimes attractive dividends come with risks that aren?t apparent at first glance. Here are 2 companies that I think could be at risk of cutting their dividend in the next couple of years:
Lifehealthcare Group Ltd (ASX: LHC) ? yields 6.4% unfranked
Lifehealthcare is a distributor of medical devices, from disposable items on up to large surgery tables and imaging devices. The company has high-ish capital requirements, as it needs to keep items in inventory for distribution to customers. This distribution business model leads to weaker cash flows and some extra vulnerability as the company must purchase an item in advance…
To keep reading, enter your email address or login below.
Sometimes attractive dividends come with risks that aren’t apparent at first glance. Here are 2 companies that I think could be at risk of cutting their dividend in the next couple of years:
Lifehealthcare Group Ltd (ASX: LHC) – yields 6.4% unfranked
Lifehealthcare is a distributor of medical devices, from disposable items on up to large surgery tables and imaging devices. The company has high-ish capital requirements, as it needs to keep items in inventory for distribution to customers. This distribution business model leads to weaker cash flows and some extra vulnerability as the company must purchase an item in advance of it being sold to customers, which means the costs come before the profits.
My concern about dividends comes because there is little buffer in the company’s financials to absorb any costs. Lifehealthcare has $1.5 million in cash. It earned $7.3 million in cash flow from operations in the last half, and spent $1.8 million on interest and tax, $3.3 million on equipment, $1.5 million on repaying debt, and a further $3.2 million on dividends.
While the second half of the year is usually stronger, it’s clear that the company can’t keep spending at the current rate. For this reason, I place a mental question mark over the company’s dividend payments.
Telstra Corporation Ltd (ASX: TLS) – yields 6.7% fully franked
Like Lifehealthcare, Telstra Corporation paid out a dividend that does not appear sustainable based on its first half, as dividend payments were greater than earnings per share – the company paid more than it earned. This is not as concerning as it might sound, as cash flows were strong, and over the full year dividend payments tend to balance out.
However, it does look as though Telstra is flirting close to the limit of what can be paid in dividends – for sure, I don’t think anybody in the market is expecting payments to increase any time soon.
The upside is that Telstra has a very stable business with reliable cash flows and attractive franking credits. While the current 6.7% dividend might not be sustainable, investors who mentally ‘marked down’ the dividend to say, 4.7%, give themselves a good margin of safety. With franking credits, 4.7% grosses up to around 6%, and there’s nothing unhealthy about that.
Of course, Telstra and Lifehealthcare are far from the only dividend shares out there. Here are 3 more that are a good opportunity at today's prices, in my opinion:
For many, blue chip stocks means stability, profitability and regular dividends, often full franked..
But knowing which blue chips to buy, and when, can often be fraught with danger.
The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.
The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor Sean O'Neill owns shares of LifeHealthcare Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.